This session will address how end-to-end supply chain strategies can assure that patients will receive timely and sustainable delivery of products. The spectrum from personalized medicines to millions of doses per year will be covered, for multiple modalities. Business continuity, raw material supply and vendor resilience, as well as manufacturing capacity and facility conversions, are critical to these strategies. The impact of the dynamics of demand (doses per year) on production strategies and operating models will also be considered. Real case studies associated with the Covid-19 pandemics treatment will be shared.
